Your session is about to expire
← Back to Search
Budesonide + Azithromycin for Laryngeal Injury after Intubation
Study Summary
This trial is aimed at investigating laryngeal injuries caused by intubation and determining risk factors to help reduce incidence or speed up diagnosis.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am unable to give consent by myself.My heart's electrical cycle is normal and I don't take QT-prolonging drugs, except amiodarone.I was on a breathing machine in the ICU for 1 to 7 days.I have cancer in my head or neck.I have a pre-existing lung condition like COPD or asthma.I am under 18 years old.I have needed help with daily activities for the last 30 days.
- Group 1: Medical Therapy
- Group 2: Placebo Control
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 30 Other Conditions - This treatment demonstrated efficacy for 30 other conditions.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there still vacancies for participants to join this research project?
"According to the clinicaltrials.gov database, this medical experiment is now enrolling participants. It was first advertised on August 19th 2017 and had its most recent update on November 3rd 2022."
What is the extent of enrollment for this scientific trial?
"Affirmative. According to records on clinicaltrials.gov, this medical trial is currently seeking patients and was originally posted in August 2017 before being updated most recently in November 2022. Approximately 64 people are required across a single site for the study to move forward."
What other empirical assessments have been made regarding Budesonide and Azithromycin as treatments?
"At present, 84 clinical investigations are being conducted with a combination of Budesonide and Azithromycin. 27 have progressed to Phase 3. These trials are chiefly located in McKinney, Texas; however, there is an expansive network of research centres across 1677 sites worldwide running studies for this therapeutic approach."
To what end are Budesonide and Azithromycin usually administered?
"Budesonide and Azithromycin are commonly prescribed to manage rhino sinusitis. They may also be effective at treating genital ulcer disease (GUD), vasomotor rhinitis, or acute coryza."
Share this study with friends
Copy Link
Messenger